ZINAPAR
Dead / Cancelled — Cancelled — Section 8 (as of 30 Jun 2017)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77278650
- Registration number
- 3880259
- Mark type
- Stylized text
- Filed
- 13 Sept 2007
- Published for opposition
- 04 Mar 2008
- Registered
- 23 Nov 2010
- Attorney of record
- Michael J. Bevilacqua, Esquire
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of cancer
Owner
- SOLASIA PHARMA K.K., TOKYO, JP
- Ziopharm Oncology, Inc., Boston, MA, US
- Ziopharm Oncology, Inc., Boston, MA, US
- Ziopharm Oncology, Inc., Boston, MA, US
Prosecution history
- 30 Jun 2017 — CANCELLED SEC. 8 (6-YR)
- 23 Nov 2015 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 May 2015 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 22 Jul 2011 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Jul 2011 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Nov 2010 — REGISTERED-PRINCIPAL REGISTER
- 21 Oct 2010 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Oct 2010 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 20 Oct 2010 — ASSIGNED TO LIE
- 14 Oct 2010 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Oct 2010 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Sept 2010 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Aug 2010 — USE AMENDMENT FILED
- 31 Aug 2010 — TEAS STATEMENT OF USE RECEIVED
- 02 Mar 2010 — SOU EXTENSION 3 GRANTED